MindWalk Holdings (HYFT) Net Cash Flow (2023 - 2026)
MindWalk Holdings (HYFT) reported Net Cash Flow of -$21.0 million for Q1 2026, down 423.2% year-over-year from $6.5 million in Q1 2025, and down 361.87% quarter-over-quarter from $8.0 million in Q4 2025.
MindWalk Holdings (HYFT) Net Cash Flow (2023 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 4 years of Net Cash Flow data on file, last reported at -$21.0 million in Q1 2026.
- Net Cash Flow for Q1 2026 came in at -$21.0 million, down 423.2% year-over-year; the trailing twelve-month figure through Jan 2026 was -$18.1 million (down 422.45% YoY), and the FY2025 annual result was $5.5 million, up 300.74% from the prior year.
- Net Cash Flow slipped to -$21.0 million in Q1 2026 per HYFT's latest filing, from $8.0 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $8.0 million in Q4 2025 and troughed at -$21.0 million in Q1 2026.
- A 4-year average of -$1.5 million and a median of -$865330.4 in 2023 frame the typical range for Net Cash Flow.
- On a YoY basis, Net Cash Flow climbed as much as 4666.47% in 2025 and fell as far as 945.92% in 2025.
- A 4-year view of Net Cash Flow shows it stood at -$471996.1 in 2023, then soared by 62.76% to -$175749.3 in 2024, then soared by 4666.47% to $8.0 million in 2025, then plunged by 361.87% to -$21.0 million in 2026.
- Business Quant data shows HYFT's Net Cash Flow at -$21.0 million in Q1 2026, $8.0 million in Q4 2025, and -$3.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.44 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 664,983.53 |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | -21.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -21.02 Mn |
| Jan 31, 2026 | -21.02 Mn |
| Oct 31, 2025 | 8.03 Mn |
| Oct 31, 2025 | 8.03 Mn |
| Jul 31, 2025 | -3.77 Mn |
| Jul 31, 2025 | -3.77 Mn |
| Apr 30, 2025 | -1.35 Mn |
| Apr 30, 2025 | -1.35 Mn |
| Jan 31, 2025 | 6.50 Mn |
| Jan 31, 2025 | 6.50 Mn |
| Oct 31, 2024 | -175,749.29 |
| Oct 31, 2024 | -175,749.29 |
| Jul 31, 2024 | 445,490.30 |
| Jul 31, 2024 | 445,490.30 |
| Apr 30, 2024 | -1.16 Mn |
| Apr 30, 2024 | -1.16 Mn |
| Jan 31, 2024 | -267,779.18 |
| Jan 31, 2024 | -267,779.18 |
| Oct 31, 2023 | -471,996.09 |
| Oct 31, 2023 | -471,996.09 |